Pharmaceutical Cartridges Market Report 2024

This Pharmaceutical Cartridges market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The pharmaceutical cartridges market size has grown strongly in recent years. It will grow from $2.05 billion in 2023 to $2.25 billion in 2024 at a compound annual growth rate (CAGR) of 9.8%. The increase observed in the historic period can be attributed to several factors, including government-led immunization programs, a rising demand for safe and convenient drug delivery methods, the expansion of the biopharmaceutical sector, growth in pharmaceutical contract manufacturing, and the rise of biologics and biosimilars.

The pharmaceutical cartridges market size is expected to see strong growth in the next few years. It will grow to $3.29 billion in 2028 at a compound annual growth rate (CAGR) of 9.9%. The projected growth during the forecast period is driven by several factors, such as a rise in injectable drug therapies, an increase in drug self-administration, a growing need for customized drug delivery solutions, a higher prevalence of chronic diseases, and an increased focus on patient compliance. Key trends expected during this period include the introduction of new products, investments in advanced medication delivery technologies, and strategic advancements in the industry.

The rising incidence of diabetes is expected to drive the growth of the pharmaceutical cartridges market in the future. Diabetes is a chronic medical condition characterized by the body's inability to effectively regulate blood sugar (glucose) levels due to inadequate insulin production or ineffective insulin usage. Factors contributing to the increasing incidence of diabetes include rising obesity rates, sedentary lifestyles, poor dietary habits, aging populations, and genetic factors. Pharmaceutical cartridges play a crucial role in diabetes management by delivering precise doses of insulin for efficient and controlled blood sugar regulation. For instance, in June 2024, the National Health Service (NHS), a UK-based government department, reported a nearly 25% increase in cases of non-diabetic hyperglycemia, or pre-diabetes, among individuals under 40, rising from 173,166 in 2022 to 216,440 in 2023. Consequently, the growing incidence of diabetes is driving the expansion of the pharmaceutical cartridges market.

Leading companies in the pharmaceutical cartridges market are focusing on developing innovative products, such as advanced self-administration systems, to enable patients to manage large volumes of biologics at home, enhancing convenience and reducing healthcare costs. These self-administration systems allow patients to administer injectables independently using technologies such as prefilled and preloaded cartridges. For instance, in July 2024, SCHOTT Pharma AG & Co. KGaA, a Germany-based healthcare firm, launched cartriQ RTU cartridges, which are 10-ml ready-to-use cartridges designed for storing and administering sensitive biologics used in treating conditions such as cancer and cardiovascular diseases. This prefilled and preloaded system simplifies self-administration, offering greater convenience and cost savings. The large-format cartridges are specifically designed to protect biologics, which are transforming the treatment of serious diseases.

In October 2023, Sharp Services, a US-based company specializing in pharmaceutical packaging and clinical trial supply services, acquired Berkshire Sterile Manufacturing (BSM) for an undisclosed amount. This acquisition is intended to enhance Sharp's capabilities in sterile injectable manufacturing by integrating small-to-medium-scale fill-finish services with its existing clinical supply and distribution solutions, providing a comprehensive and efficient solution for biopharmaceutical clients. Berkshire Sterile Manufacturing (BSM) is a US-based company that offers pharmaceutical cartridges as part of its sterile filling services.

Major companies operating in the pharmaceutical cartridges market are Merck KGaA, Becton Dickinson and Company (BD), Baxter Healthcare Corporation, Clariant AG, Terumo Corporation, Catalent Inc., Sigma-Aldrich Corporation, Nipro Corporation, Schott AG, West Pharmaceutical Services Inc., Gerresheimer AG, Vetter Pharma International GmbH, Dätwyler Holding Inc., Camfil AB, Stevanato Group S.p.A., groninger and Co. gmbh, Shandong Medicinal Glass Co. Ltd., Ypsomed AG, SGD Pharma, Consort Medical plc.

North America was the largest region in the pharmaceutical cartridges market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical cartridges market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmaceutical cartridges market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Pharmaceutical cartridges are cylindrical vessels, usually made of glass or plastic, designed to hold and dispense accurate doses of liquid medications through injectors or drug delivery systems. They play a crucial role in ensuring precise dosing while maintaining the medication's sterility and stability, making them essential for injectable treatments.

There are two main types of pharmaceutical cartridges dual chamber cartridges and large-volume cartridges. Dual chamber cartridges are specialized units that contain two distinct substances, such as a medication and a diluent, which are mixed at the time of injection. These cartridges are frequently used for medications that require on-demand mixing. They are made from materials such as glass, plastic, and rubber, and are used in various applications such as dental anesthesia, pen injectors, autoinjectors, and wearable injectors, catering to end users in pharmaceuticals, biotechnology, research institutions, and more.

The pharmaceutical cartridges market research report is one of a series of new reports that provides pharmaceutical cartridges market statistics, including pharmaceutical cartridges industry global market size, regional shares, competitors with a pharmaceutical cartridges market share, detailed pharmaceutical cartridges market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical cartridges industry. This pharmaceutical cartridges market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceutical cartridges market consists of sales of prefilled syringes, single-chamber cartridges, custom-shaped cartridges, small-volume cartridges, multi-dose cartridges, and needle-free cartridges. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.